GO
Loading...

Enter multiple symbols separated by commas

Pfizer Inc

More

  • NEW YORK— Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:. SuperValu Inc., up 78 cents to $8.14. Masco Corp., up $2.47 to $25.63.

  • *Baidu slumps after results miss expectations. China's top securities regulator said on Monday that Beijing would keep buying shares to stabilize the market, after the steepest decline in Chinese stocks in eight years. Baidu slumped as much as 17.7 percent to $162.72 after China's biggest Internet search company's quarterly profit missed estimates.

  • *Baidu slumps after results miss expectations. *Pfizer, Ford rise after results. Wall Street sank on Monday, for the fifth straight day, after the steepest decline in Chinese stocks in eight years increased concerns about slowing growth in the country.

  • July 28- Pfizer Inc reported better-than-expected quarterly profit and revenue, helped by strong demand for its pneumonia vaccine Prevnar 13 and sales of its breast cancer drug, Ibrance. The unit accounted for about 13 percent of Pfizer's total revenue. Pfizer's shares rose about 2 percent in premarket trading on Tuesday.

  • Dissecting big pharma's numbers: Pro

    Barbara Ryan, Clermont Partners, breaks down Pfizer and Merck's quarterly results and shares her outlook on the pharmaceutical sector.

  • *Wall Street sank on Monday, for the fifth straight day, after the steepest decline in Chinese stocks in eight years increased concerns that cooling growth in the world's No. 2 economy could hurt China's trading partners. *With second-quarter reports well under way, analysts expect overall earnings of S&P 500 companies to dip 0.3 percent, below the 3- percent...

  • Pfizer Inc. beat Wall Street's second-quarter expectations and raised its 2015 forecast, as soaring sales for a few key products helped inoculate the world's second-largest drugmaker against a $1 billion revenue hit from foreign exchange rates and its last wave of cheap generic competition hurting former big sellers. Pfizer's experimental drugs "could...

  • July 28- U.S. drugmaker Pfizer Inc reported a 7 percent fall in quarterly revenue, hurt by a strong dollar. The company's net income fell to $2.63 billion, or 42 cents per share, in the second quarter, from $2.91 billion, or 45 cents per share, a year earlier. Revenue fell to $11.85 billion from $12.77 billion.

  • Mylan, whose shares fell 14.5 percent, said it would continue its own unsolicited pursuit of Irish drugmaker Perrigo Co, a maker of over-the-counter consumer and nutritional products and generic topical medicines. Perrigo is one of the few remaining assets out there, "said Morningstar analyst Michael Waterhouse. Other industry analysts expect Mylan will...

  • NEW YORK, July 27- Allergan CEO Brent Saunders said on Monday the company will use the $36 billion it nets from the sale of its generics business to Teva for more deals, including large, "transformational" merger opportunities. Saunders, who led the $66 billion combination of Actavis and Allergan that closed only a few months ago, told investors that it would use the...

  • Minefield for market with Fed, earnings, commodities Monday, 27 Jul 2015 | 8:08 AM ET
    An oil trader works on the floor of the New York Mercantile Exchange.

    The Fed meets next week, but a commodities meltdown and earnings season are adding to concerns about global growth and may steal some of its thunder.

  • What to expect from Merck & Pfizer tomorrow Monday, 27 Jul 2015 | 6:52 AM ET
    What to expect from Merck & Pfizer tomorrow

    CNBC's Dominic Chu reports on Kensho studies, looking at Merck and Pfizer's stock performances around quarterly reports.

  • SYDNEY/ HONG KONG, July 27- Asian shares began the week on a plaintive note amid losses on Wall Street and worries over China, while investors braced for a Federal Reserve meeting that might take another small step toward lifting U.S. interest rates. Financial spreadbetters expected Britain's FTSE 100 0.3 percent lower, Germany's to open 0.4 percent down, and...

  • SYDNEY, July 27- Asian shares began the week on a plaintive note amid losses on Wall Street and worries over China, while investors braced for a Federal Reserve meeting that might take another small step toward lifting U.S. interest rates. Japan's Nikkei slipped 0.5 percent, while MSCI's broadest index of Asia-Pacific shares outside Japan lost 0.8 percent.

  • *Most Asian stock markets lower tracking Wall St. SYDNEY, July 27- Asian shares began the week on a plaintive note amid losses on Wall Street and worries over China, while investors braced for a Federal Reserve meeting that might take another small step toward lifting U.S. interest rates. Japan's Nikkei slipped 0.8 percent in early trade, while MSCI's broadest...

  • The United States, New Zealand and Australia are pushing hard for Canada to open up its protected dairy market and allow more imports, complaining that the country has not given its trade partners a sign it is ready to talk and even mulling a TPP without Canada. Sugar refiner Imperial Sugar Co, part of Louis Dreyfus Commodities, says Australia should be allowed to...

  • A look at the largest companies in the S&P 500 Friday, 24 Jul 2015 | 7:08 PM ET

    Amazon surpassed the world's largest retailer, Wal-Mart Stores Inc., in market value Friday, on the back of a strong earnings report. Amazon shares closed up nearly 10 percent, giving the Seattle company a market value of $247.77 billion, versus $230.53 billion for Wal-Mart. A company's market value is calculated by multiplying the number of shares of stock it...

  • WASHINGTON— The Food and Drug Administration on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades. The drug from Sanofi and Regeneron Pharmaceuticals Inc. offers an important new option for millions of patients at high risk of heart disease. But the drug's sky-high...

  • Buy the dip? Here's the bullish case now Friday, 24 Jul 2015 | 1:53 PM ET
    Traders work on the floor of the New York Stock Exchange.

    Two Strategists favor U.S. stocks vs. global stocks

  • Health care takes earnings hot hand into week ahead Friday, 24 Jul 2015 | 10:23 AM ET
    Pfizer headquarters in New York.

    Health-care stocks are batting 12 for 12 in beating earnings estimates. Will the streak last?